Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
Bridged bicyclic aromatic compounds are provided having the structure STR1 wherein R1, R2, R3, R4, R5 and n are as defined herein. The novel compounds are useful for modulating gene expression of retinoic acid receptors, vitamin D receptors and thyroid receptors. Pharmaceutical compositions and methods for modulating gene expression are provided as well.
-
(2008/06/13)
More Articles about upstream products of 156910-57-5